Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease | Zendy

Carlo Alberto Artusi | Zendy; Alok Dwivedi | Zendy; Alberto Romagnolo | Zendy; Gian Pal | Zendy; Marcelo Kauffman | Zendy; Ignácio F. Mata | Zendy; Dhiren Patel | Zendy; Joaquín A. Vizcarra | Zendy; Andrew P. Duker | Zendy; Luca Marsili | Zendy; Binith Cheeran | Zendy; Daniel Woo | Zendy; Maria Fiorella Contarino | Zendy; L. Verhagen | Zendy; Leonardo Lopiano | Zendy; Alberto J. Espay | Zendy; Alfonso Fasano | Zendy; Aristide Merola | Zendy

Open Access

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease

Author(s) -

Carlo Alberto Artusi,

Alok Dwivedi,

Alberto Romagnolo,

Gian Pal,

Marcelo Kauffman,

Ignácio F. Mata,

Dhiren Patel,

Joaquín A. Vizcarra,

Andrew P. Duker,

Luca Marsili,

Binith Cheeran,

Daniel Woo,

Maria Fiorella Contarino,

L. Verhagen,

Leonardo Lopiano,

Alberto J. Espay,

Alfonso Fasano,

Aristide Merola

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2018.7800

Subject(s) - deep brain stimulation , subthalamic nucleus , rating scale , parkinson's disease , levodopa , medicine , movement disorders , disease , physical medicine and rehabilitation , cohort , psychology , pediatrics , physical therapy , developmental psychology

Key Points Question Does the outcome of subthalamic deep brain stimulation vary among common monogenic forms of Parkinson disease? Findings In this systematic review and meta-analysis involving 518 patients from 17 published studies, treatment with subthalamic deep brain stimulation for patients with Parkinson disease with LRRK2 , GBA , or PRKN gene mutation yielded similar motor outcomes but different changes in dopaminergic doses, activities of daily living, motor complications, and cognitive functions. Meaning Genetic screening for LRRK2, GBA, and PRKN mutations in patients with Parkinson disease who are candidates for subthalamic deep brain stimulation may serve to inform outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research